Literature DB >> 27344458

Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Nicholas Kavoussi1, Noah Canvasser1, Jeffrey Caddedu2.   

Abstract

The widespread utilization of abdominal imaging has led to an increase in incidentally detected small renal masses. Although partial nephrectomy is still considered the gold standard treatment for these masses, there are risks associated with surgical excision, potentially limiting treatment for older patients with multiple comorbidities. A variety of ablative techniques have developed over the past several decades, altering the management of small renal masses. It is likely that improvements in technology will only broaden the applications of ablative therapy. This article provides an update on the various ablative techniques and outcomes.

Entities:  

Keywords:  Ablation; Small renal mass

Mesh:

Year:  2016        PMID: 27344458     DOI: 10.1007/s11934-016-0611-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  60 in total

1.  Percutaneous Renal Cryoablation: Short-Axis Ice-Ball Margin as a Predictor of Outcome.

Authors:  Benjamin H Ge; Thomas J Guzzo; Gregory J Nadolski; Michael C Soulen; Timothy W I Clark; Stanley B Malkowicz; Alan J Wein; Stephen J Hunt; S William Stavropoulos
Journal:  J Vasc Interv Radiol       Date:  2016-01-02       Impact factor: 3.464

2.  High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation.

Authors:  Anna J Moreland; Timothy J Ziemlewicz; Sara L Best; J Louis Hinshaw; Meghan G Lubner; Marci L Alexander; Christopher L Brace; Douglas R Kitchin; Sean P Hedican; Stephen Y Nakada; Fred T Lee; E Jason Abel
Journal:  J Endourol       Date:  2014-07-02       Impact factor: 2.942

3.  ABLATE: a renal ablation planning algorithm.

Authors:  Grant D Schmit; A Nicholas Kurup; Adam J Weisbrod; R Houston Thompson; Stephen A Boorjian; C Thomas Wass; Matthew R Callstrom; Thomas D Atwell
Journal:  AJR Am J Roentgenol       Date:  2014-04       Impact factor: 3.959

4.  Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.

Authors:  Casey A Seideman; Jeffrey Gahan; Matthew Weaver; Ephrem O Olweny; Michael Richter; Danny Chan; Jeffrey A Cadeddu
Journal:  BJU Int       Date:  2013-12       Impact factor: 5.588

5.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

Review 6.  Microwave tumor ablation: mechanism of action, clinical results, and devices.

Authors:  Meghan G Lubner; Christopher L Brace; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

7.  Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters.

Authors:  Sara L Best; Samuel K Park; Ramy F Youssef; Ramy F Yaacoub; Ephrem O Olweny; Yung K Tan; Clayton Trimmer; Jeffrey A Cadeddu
Journal:  J Urol       Date:  2012-02-14       Impact factor: 7.450

8.  Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.

Authors:  Scott M Castle; Nelson Salas; Raymond J Leveillee
Journal:  Urology       Date:  2011-02-16       Impact factor: 2.649

9.  Hypothermia and acidosis synergistically impair coagulation in human whole blood.

Authors:  Daniel Dirkmann; Alexander A Hanke; Klaus Görlinger; Jürgen Peters
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

10.  Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates.

Authors:  Gladwin C Hui; Kemal Tuncali; Servet Tatli; Paul R Morrison; Stuart G Silverman
Journal:  J Vasc Interv Radiol       Date:  2008-07-21       Impact factor: 3.464

View more
  4 in total

Review 1.  Treatment approaches to small renal masses in patients of advanced age (≥75 years).

Authors:  Muhammet Fuat Özcan; Serkan Altınova; Ali Atan
Journal:  Turk J Urol       Date:  2018-07

2.  Are the long-term outcomes of percutaneous ablation for clinical stage T1 renal tumors similar to those of partial nephrectomy?

Authors:  Roy Mano; A Ari Hakimi
Journal:  Ann Transl Med       Date:  2019-12

Review 3.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

Review 4.  Available ablation energies to treat cT1 renal cell cancer: emerging technologies.

Authors:  P J Zondervan; M Buijs; D M De Bruin; O M van Delden; K P Van Lienden
Journal:  World J Urol       Date:  2018-11-17       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.